不同模式间歇低氧血管内皮损伤机制的研究
|
摘要
研究背景与目的:
睡眠呼吸暂停综合征的病理损伤核心因素是体内长期存在的间歇低氧/再氧合环境,因其显著的多系统损害被认为是全身性疾病。在OSAS诸多靶器官损害中,血管内皮功能障碍发挥着关键作用,血管内皮结构与功能的损害与动脉粥样硬化、内皮依赖性血管舒张功能障碍、凝血机制紊乱密切相关。但是慢性间歇低氧导致内皮损伤的机制,低氧程度、低氧频率与内皮损伤程度的相关性尚未完全清楚。鉴于上述原因,我们建立了间歇低氧人脐静脉内皮细胞模型,探讨不同间歇低氧模式(不同IH程度、不同IH频率、不同IH程度累加不同IH频率)下血管内皮细胞分泌ROS、氧化还原敏感的转录因子及相应炎症介质的变化,以及他们之间的相互关系,进一步明确间歇低氧导致内皮损伤的机制;同时探讨不同类型的CIH所导致的内皮细胞的氧化应激与炎症状态的差异,从而为临床治疗提供实验数据和理论依据。
内容:
1.不同模式CIH暴露人脐静脉内皮细胞氧化应激反应的研究
2.不同模式CIH、ROS与氧化还原敏感转录因子的研究
3.不同CIH与黏附分子及肿瘤坏死因子α的研究
方法:
应用计算机程控装置输送不同氧浓度的气体制造内皮细胞间歇低氧暴露内环境,分为三种间歇低氧程度,五种低氧频率,以间歇正常氧为对照。应用ELISA分别检测细胞分泌的培基中GSH-PX与MDA; ICAM-1与TNF-α; Western-Blot检测细胞质中HIF-1,细胞质和细胞核中的NF-κB浓度,EMSA检测NF-κB的DNA结合活性。
结果:
第一部分:
1.在特定IH条件下,不同IH频率暴露MDA结果不同(F=652.88, P =0.00)。绘制MDA随IH频率变化的曲线,呈山峰状,非直线性。顶点在20次/H;就抗氧化能力而言,不同IH频率暴露GSH-PX结果不同(F=12300,P=0.00),大多减低,9/h组GSH-PX明显高于对照组和其他间歇低氧暴露和持续低氧组。
2.在固定IH频率12次/H时,不同IH程度,MDA(F=503.06, P=0.00), GSH(F=23390, P=0.00)结果不同。
3.三种低氧程度与五个IH频率共15种组合的暴露条件下MDA、GSH-PX浓度的检测,经过析因设计资料的方差分析后,结果显示两个变量均存在IH程度与IH频率的交互作用, MDA(F=94.14, P=0.00),GSH(F=173.18, P=0.00)。
4.双变量相关分析法显示:相关系数r=-0.52, P=0.00,提示MDA与GSH-PX呈负相关关系。
第二部分:
1. CIH与对照组及SH比较统计结果显示:胞质NF-κB的含量(F=1.71,P=0.19),各组间无统计学差异;胞核NF-κB的含量(F=15206, P=0.00),各组间具有统计学差异,CIH暴露组明显高于对照组及持续低氧组。在固定IH1.5%O_2条件下,IH频率不同的各组胞核的NF-κB的水平不同(F=74.42, P=0.00),具有统计学差异。
2. EMSA NF-κB DNA结合活性检测结果显示三种低氧程度与五个IH频率共15种组合的暴露组间存在差异(F=33.1 1, P=0.00),析因设计资料的方差分析显示存在交互作用。
3. 15种CIH模式的NF-κB DNA结合活性与相应的GSH-PX相关性分析(r=-0. 51, P=0. 00),存在负相关。
4.12次/h, 1. 5%的间歇低氧暴露模式,HIF-1不表达。
5.1.5%O_2暴露不同频率c-fosmRNA的水平不同(F=67.05, P=0.00),随频率增加出现增加后下降趋势。频率为12/h组与其他各组比较,P<0.01。
第三部分:
1.固定频率12次/h的间歇低氧暴露TNF-α和ICAM-1均高于对照组及持续低氧组。(F=668.41, P=0.00)
2.间歇低氧程度与频率TNF-α(F=168. 06, P=0. 00)和ICAM-1(F=39. 06,P=0. 00)均表现出了明显交互作用。
3.在炎症因子与NF-κB的相关性分析中发现,TNF-α(r=0. 19, P=0. 22)和ICAM-1( r=0. 27, P=0. 06)与NF-κB DNA结合活性的相关性不明显。
结论:
1.本研究发现血管内皮细胞不同模式IH暴露下,表现出氧化应激与炎症损伤,但也发现部分CIH模具有保护效应。
2.不同模式CIH对于氧化应激和转录因子激活、炎症反应均存在差异,显示了IH程度与频率的交互效应。
3. CIH选择性激活炎症通道,未见适应性通道的激活
4.氧化应激损伤可能作为始动因素进而导致炎症反应,NF-κB与氧化应激等共同影响炎症因子的释放
本课题的创新点:
1.目前尚未见离体人血管内皮细胞进行不同模式CIH暴露研究报告;
2.目前未见不同间歇低氧程度和频率内皮损伤机制关系的研究报告;
3.不同的IH/ROX模式导致内皮细胞氧化应激与炎症,不同程度、频率IH暴露下,内皮细胞表现出了损伤效应。部分CIH模式有促使抗氧化能力升高的效应.
思考:
1.深入研究氧化应激与炎症反应的相互作用
2.继续抗氧化与抗炎干预性研究
3.尝试寻求机体适应性的CIH模式
Background and objective:
OSAS is seemed to be a systemic disease.People with chronic IH are prone tocardiac and vascular damages.Much attention has been paid to endothelialdysfunction,which is regarded as the contributors to vascular diseases.Endothelialdysfunction can induce atherosclerosis,impairment of endothelium-dependentvasodilatation and blood coagulation disorder.The long-standing IH/ROX is the keypathology of Obstructive sleep apnea syndrome (OSAS),Chronic intermittenthypoxemia may be responsible for triggering endothelial dysfunction in OSAS.Butthe mechanism about it is not very clear,so we estimate a model to mime theoccurrence of intermittent hypoxia,investigating the difference of oxidative andinflammatory level of endothelial cell which is exposed in various intermittenthypoxia environments,The purpose is to approach the possible mechanism of CIHrelated vascular endothelial impairment.
Contents:
1.The research about CIH and oxidative stress,the HUVECs exposed in differentCIH styles
2.The research about CIH and oxidoreduction sensitive transcription factors
3.The research about CIH and inflammatory factors.
Methods:
Set up a different intermittent hypoxia environment of HUVECs by computercontrol.Divided different groups by three level oxygen concentration and five IHfrequency.Investigate the level of GSH-PX,MDA,TNF-αand ICAM-1 by ELISAmethod;Detect NF-κB and HIF-1 by Western-Blot,the activity of NF-κB DNAcombination by EMSA.
Results:
The first part:
1.In different IH frequency exposure,the levels of MDA were higher than controland SH group.For GSH-PX,the levels were different to different IH frequency,most of them were higher than control and SH group,but for an exceptionalresult,in the group of 9/h,the level of it was increased markedly than controlgroup.
2.In different IH degree,the levels of MDA and GSH-PX were all increased.
3.We found the interplay between IH degree and frequency by analysis the 15 CIHstyles
4.In the relational analysis of GSH-PX and MDA,we found the negativecorrelation between them.
The second part:
1.For NF-κB,the concentration in cell plasma had no difference with control andSH group,but in nucleolus,the NF-κB concentration was higher evidently thanother groups.
2.For the detecting of the DNA combinational activity of NF-κB,we also foundthe difference in 15 groups and the interplaying between IH degree andfrequency.
3.The result of correlation analysis between GSH-PX and the combinationalactivity of NF-κB,the index is r=-0.51,P=0.00,significant negative correlation.
4.In the expression of CIH (IH=1.5% O_2,frequency 12/h),we did not find theexpression of HIF-1.
5.In the expression of the c-fox mRNA,we found the difference expressionbetween the different IH frequency,the group frequency 12/h was higher thanothers.
The third part:
1.In the fix up frequency of 12/h,we found the difference levels of TNF-αandICAM-1 between CIH with control and SH groups.
2.In the testing ofTNF-αand ICAM-1 in 15 groups,we found the interplay ofIH degree and frequency too.
3.In the correlation analysis of combinational activity of NF-κB to TNF-αandICAM-1,we did not detect significant correlations.
Conclusions:
1.To HUVECs,the exposure to different CIH styles prone to oxidative stressand inflammatory damages,but we found a exceptional type,which hadprotecting effects.
2.The exposure of different CIH styles were with different degrees of vascularendothelial impairment,but the variable trend was irregular.We found theevident interplay effects between IH degree and IH frequency.
3.CIH active the inflammatory transcriptional factors selectively,we did notdetect the active of adaptable pathway HIF-1.
4.In our research,we consider oxidative stress may be the original factor,which can induce the activation of NF-κB,the link between CIH andinflammatory factors.NF-κB and oxidative stress co-operate to effect therelease of inflammatory factors.
睡眠呼吸暂停综合征的病理损伤核心因素是体内长期存在的间歇低氧/再氧合环境,因其显著的多系统损害被认为是全身性疾病。在OSAS诸多靶器官损害中,血管内皮功能障碍发挥着关键作用,血管内皮结构与功能的损害与动脉粥样硬化、内皮依赖性血管舒张功能障碍、凝血机制紊乱密切相关。但是慢性间歇低氧导致内皮损伤的机制,低氧程度、低氧频率与内皮损伤程度的相关性尚未完全清楚。鉴于上述原因,我们建立了间歇低氧人脐静脉内皮细胞模型,探讨不同间歇低氧模式(不同IH程度、不同IH频率、不同IH程度累加不同IH频率)下血管内皮细胞分泌ROS、氧化还原敏感的转录因子及相应炎症介质的变化,以及他们之间的相互关系,进一步明确间歇低氧导致内皮损伤的机制;同时探讨不同类型的CIH所导致的内皮细胞的氧化应激与炎症状态的差异,从而为临床治疗提供实验数据和理论依据。
内容:
1.不同模式CIH暴露人脐静脉内皮细胞氧化应激反应的研究
2.不同模式CIH、ROS与氧化还原敏感转录因子的研究
3.不同CIH与黏附分子及肿瘤坏死因子α的研究
方法:
应用计算机程控装置输送不同氧浓度的气体制造内皮细胞间歇低氧暴露内环境,分为三种间歇低氧程度,五种低氧频率,以间歇正常氧为对照。应用ELISA分别检测细胞分泌的培基中GSH-PX与MDA; ICAM-1与TNF-α; Western-Blot检测细胞质中HIF-1,细胞质和细胞核中的NF-κB浓度,EMSA检测NF-κB的DNA结合活性。
结果:
第一部分:
1.在特定IH条件下,不同IH频率暴露MDA结果不同(F=652.88, P =0.00)。绘制MDA随IH频率变化的曲线,呈山峰状,非直线性。顶点在20次/H;就抗氧化能力而言,不同IH频率暴露GSH-PX结果不同(F=12300,P=0.00),大多减低,9/h组GSH-PX明显高于对照组和其他间歇低氧暴露和持续低氧组。
2.在固定IH频率12次/H时,不同IH程度,MDA(F=503.06, P=0.00), GSH(F=23390, P=0.00)结果不同。
3.三种低氧程度与五个IH频率共15种组合的暴露条件下MDA、GSH-PX浓度的检测,经过析因设计资料的方差分析后,结果显示两个变量均存在IH程度与IH频率的交互作用, MDA(F=94.14, P=0.00),GSH(F=173.18, P=0.00)。
4.双变量相关分析法显示:相关系数r=-0.52, P=0.00,提示MDA与GSH-PX呈负相关关系。
第二部分:
1. CIH与对照组及SH比较统计结果显示:胞质NF-κB的含量(F=1.71,P=0.19),各组间无统计学差异;胞核NF-κB的含量(F=15206, P=0.00),各组间具有统计学差异,CIH暴露组明显高于对照组及持续低氧组。在固定IH1.5%O_2条件下,IH频率不同的各组胞核的NF-κB的水平不同(F=74.42, P=0.00),具有统计学差异。
2. EMSA NF-κB DNA结合活性检测结果显示三种低氧程度与五个IH频率共15种组合的暴露组间存在差异(F=33.1 1, P=0.00),析因设计资料的方差分析显示存在交互作用。
3. 15种CIH模式的NF-κB DNA结合活性与相应的GSH-PX相关性分析(r=-0. 51, P=0. 00),存在负相关。
4.12次/h, 1. 5%的间歇低氧暴露模式,HIF-1不表达。
5.1.5%O_2暴露不同频率c-fosmRNA的水平不同(F=67.05, P=0.00),随频率增加出现增加后下降趋势。频率为12/h组与其他各组比较,P<0.01。
第三部分:
1.固定频率12次/h的间歇低氧暴露TNF-α和ICAM-1均高于对照组及持续低氧组。(F=668.41, P=0.00)
2.间歇低氧程度与频率TNF-α(F=168. 06, P=0. 00)和ICAM-1(F=39. 06,P=0. 00)均表现出了明显交互作用。
3.在炎症因子与NF-κB的相关性分析中发现,TNF-α(r=0. 19, P=0. 22)和ICAM-1( r=0. 27, P=0. 06)与NF-κB DNA结合活性的相关性不明显。
结论:
1.本研究发现血管内皮细胞不同模式IH暴露下,表现出氧化应激与炎症损伤,但也发现部分CIH模具有保护效应。
2.不同模式CIH对于氧化应激和转录因子激活、炎症反应均存在差异,显示了IH程度与频率的交互效应。
3. CIH选择性激活炎症通道,未见适应性通道的激活
4.氧化应激损伤可能作为始动因素进而导致炎症反应,NF-κB与氧化应激等共同影响炎症因子的释放
本课题的创新点:
1.目前尚未见离体人血管内皮细胞进行不同模式CIH暴露研究报告;
2.目前未见不同间歇低氧程度和频率内皮损伤机制关系的研究报告;
3.不同的IH/ROX模式导致内皮细胞氧化应激与炎症,不同程度、频率IH暴露下,内皮细胞表现出了损伤效应。部分CIH模式有促使抗氧化能力升高的效应.
思考:
1.深入研究氧化应激与炎症反应的相互作用
2.继续抗氧化与抗炎干预性研究
3.尝试寻求机体适应性的CIH模式
Background and objective:
OSAS is seemed to be a systemic disease.People with chronic IH are prone tocardiac and vascular damages.Much attention has been paid to endothelialdysfunction,which is regarded as the contributors to vascular diseases.Endothelialdysfunction can induce atherosclerosis,impairment of endothelium-dependentvasodilatation and blood coagulation disorder.The long-standing IH/ROX is the keypathology of Obstructive sleep apnea syndrome (OSAS),Chronic intermittenthypoxemia may be responsible for triggering endothelial dysfunction in OSAS.Butthe mechanism about it is not very clear,so we estimate a model to mime theoccurrence of intermittent hypoxia,investigating the difference of oxidative andinflammatory level of endothelial cell which is exposed in various intermittenthypoxia environments,The purpose is to approach the possible mechanism of CIHrelated vascular endothelial impairment.
Contents:
1.The research about CIH and oxidative stress,the HUVECs exposed in differentCIH styles
2.The research about CIH and oxidoreduction sensitive transcription factors
3.The research about CIH and inflammatory factors.
Methods:
Set up a different intermittent hypoxia environment of HUVECs by computercontrol.Divided different groups by three level oxygen concentration and five IHfrequency.Investigate the level of GSH-PX,MDA,TNF-αand ICAM-1 by ELISAmethod;Detect NF-κB and HIF-1 by Western-Blot,the activity of NF-κB DNAcombination by EMSA.
Results:
The first part:
1.In different IH frequency exposure,the levels of MDA were higher than controland SH group.For GSH-PX,the levels were different to different IH frequency,most of them were higher than control and SH group,but for an exceptionalresult,in the group of 9/h,the level of it was increased markedly than controlgroup.
2.In different IH degree,the levels of MDA and GSH-PX were all increased.
3.We found the interplay between IH degree and frequency by analysis the 15 CIHstyles
4.In the relational analysis of GSH-PX and MDA,we found the negativecorrelation between them.
The second part:
1.For NF-κB,the concentration in cell plasma had no difference with control andSH group,but in nucleolus,the NF-κB concentration was higher evidently thanother groups.
2.For the detecting of the DNA combinational activity of NF-κB,we also foundthe difference in 15 groups and the interplaying between IH degree andfrequency.
3.The result of correlation analysis between GSH-PX and the combinationalactivity of NF-κB,the index is r=-0.51,P=0.00,significant negative correlation.
4.In the expression of CIH (IH=1.5% O_2,frequency 12/h),we did not find theexpression of HIF-1.
5.In the expression of the c-fox mRNA,we found the difference expressionbetween the different IH frequency,the group frequency 12/h was higher thanothers.
The third part:
1.In the fix up frequency of 12/h,we found the difference levels of TNF-αandICAM-1 between CIH with control and SH groups.
2.In the testing ofTNF-αand ICAM-1 in 15 groups,we found the interplay ofIH degree and frequency too.
3.In the correlation analysis of combinational activity of NF-κB to TNF-αandICAM-1,we did not detect significant correlations.
Conclusions:
1.To HUVECs,the exposure to different CIH styles prone to oxidative stressand inflammatory damages,but we found a exceptional type,which hadprotecting effects.
2.The exposure of different CIH styles were with different degrees of vascularendothelial impairment,but the variable trend was irregular.We found theevident interplay effects between IH degree and IH frequency.
3.CIH active the inflammatory transcriptional factors selectively,we did notdetect the active of adaptable pathway HIF-1.
4.In our research,we consider oxidative stress may be the original factor,which can induce the activation of NF-κB,the link between CIH andinflammatory factors.NF-κB and oxidative stress co-operate to effect therelease of inflammatory factors.
引文
[1]Guilleminault C,Tilkian A,Dement WC.The sleep apnea syndromes[J].Annu Rev Med.1976,27:465-484.
[2]Young T,Palta M,Dempsey J,et al.The occurrence of sleep-disordered breathing among middle-aged adults[J].N Engl Med,1993,328(17):1230-1235.
[3]Shamsuzzaman AS,Gersh B J,Somers VK.Obstructive sleep apnea:implications for cardiac and vascular disease [J].JAMA,2003,290:1906-1914
[4]Schulz R,Grebe M,Eisele HJ,etal.Obstructive sleep apnea-related cardiovascular disease Med Klin (Munich) [J].2006,101(4):321-327.
[5]Peppard PE,Young T,Palta M,etal.Prospective study of the association between sleep-disordered breathing and hypertension [J].N Engl J Med,2000,342:1378-84.
[6]Quan SF,Wright R,Baldwin CM,et al.Obstructive sleep apnea-hypoapnea and neurocognitive functioning in the Sleep Heart Health Study[J].Sleep Med,2006,7(6):498-507.
[7]Fletcher EC,Lesske J,Qian W,et al.episodic hypoxia causes diurnal elevation of blood pressure in rats [J].Hypertension,1992,19:555-561.
[8]Fletcher EC,Bao G,Miller CC 3~(rd).Effect of recurrent episodic hypocapnic,eucapnic,and hypercapnic hypoxia on systemic blood pressure [J].J Appl Physiol,1995,78:1516-1521.
[9]Fletcher EC,Bao G.Effect of episodic eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension-prone rats [J].J Appl Physiol,1996,81(5):2088-2094.
[10]Lavie L.Sleep-disordered breathing and cerebrovascular disease:a mechanistic approach [J].Neurol Clin,2005,23:1059-1075.
[11]Vgantzas AN,Papanicolaou DA,Bixler EO.Elevation of plasma cytokines in disorders of excessive daytime sleepiness:role of sleep disturbance and obesity [J]. J Clin Endocrinol Metab, 1997, 82:1313-1316.
[12] Shamsuzzaman AS,Winniciki M,Lanfranchi P,et al.Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Cireculation , 2002, 105:2462-2464.
[13] Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea[J]. Ann N Y Acad Sci, 2005,1051:340-350.
[14] Dyugovskaya L, Lavie P,Hirsh M, et al. Actinated CD8~+ lymphocytes in obstructive sleep apnea[J]. Eur Respir J, 2005,25:820-828.
[15] Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea[J]. Am J Respir Crit Care Med, 2003, 168: 242-249
[16] Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients[J]. Am J Respir Crit Care Med, 2002,165: 934-939.
[17] Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients [J]. Am J Respir Crit Care Med , 2002, 165:934-939.
[18] Zhan G, Serrano F, Fenik P, et al: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea [J]. Am J Respir Crit Care Med [J], 2005,172: 921- 929.
[19] Antoinette W, Steven M.. Obstructive sleep apnea cardiovascular disease,and inflammation-is NF-kB the key? [J]. Sleep Breath, 2007, 11: 69-76.
[20] Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up [J]. Am J Respir Crit Care Med, 2002, (165): 159-165.
[21] Dureanteau J, Chandel NS, Kulisz A et al. Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes[J]. J Biol Chem, 1998, 273: 11619-11624.
[22] Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from poly morpho nuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy [J]. Am J Respir Crit Care Med, 2000,162: 566-570.
[23] Lavie L. Obstructive sleep apnea syndrome -an oxidative disorder [J] . Sleep Med Rev, 2003, 7:35-51.
[24] McNicholas WT. Obstructive Sleep Apnea and Inflammation [J]. Progress in Cardiovascular Diseases, 2009, 51(5): 392-399.
[25] Bassenge E, Schneider HT, Daiber A. Oxidative stress and cardiovascular diseases[J ]. Dtsch Med Wochenschr, 2005 ,130(50): 2904-2909.
[26] Heistad DD. Oxidative stress and vascular disease [J ]. Arterioscler Thromb Vasc Biol, 2005,12:104.
[27] Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients[J]. Am J Respir Crit Care Med, 2002,165: 934-939.
[28] Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients [J]. Am J Respir Crit Care Med , 2002, 165:934-939.
[29] Zhan G, Serrano F, Fenik P, et al: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea [J]. Am J Respir Crit Care Med [J], 2005,172: 921- 929.
[30] Dean RT,Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep aonea [J] .Sleep, 1993, 16: S15-21.
[31] Halliwell B. The role of oxygen radicals in human disease,with particular reference to the vascular system [J]. Haemostasis, 1993, 23: 118-126.
[32] Dureanteau J, Chandel NS, Kulisz A et al. Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes [J] . J Biol Chem, 1998,273: 11619-11624.
[33] Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from poly morpho nuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy [J]. Am J Respir Crit Care Med, 2000, 162: 566-570.
[34] Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and esabilization [J]. Stroke, 2006, 37:1923-1932.
[35] Sanders SP, Zweier JL, Kuppusamy P et al. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron Transport [J]. J Clin Invest, 1993, 91: 46-52.
[36] Marshall C, Mamary AJ, Verhoeven AJ,et al. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction [J]. Am J Resp Cell Mol Biol,1996,15:633-644.
[37] Ahmadinejad M, Thornton J , Sutton R, et al. Mitochondrial changes following ischaemic-reperfusion injury in the sheep large intestine [J] . Indian J of Veterinary Surg, 1994 ,15 (6) :126.
[38] Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension [J]. N Engl J Med, 2000, 342: 1378-84.
[39] Luc G, Bard JM, Juhan-Vague I, et al. C-Reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study[J].Arterioscler Thromb Vasc Biol, 2003, 23:1255-1261.
[40] Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996, 94: 874-877.
[41] Ueda K, Takahashi M, Ozawa K, et al. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction [J]. Am Heart J, 1999,138(5 Pt 1): 908-915.
[42] Baldwin AS Jr. The NF-kB and IkBα proteins : new discoveries and insights[J]. Annu Rev Immunol, 1996 , 14 : 649 - 681.
[43] Liao F , Andalibi AI ,Qiao JH , et al. Genetic evidence for a common Pathway mediating oxidative stress , inflammatory gene induction , and aortic fatty streak formation in mice[J]. J Clin Invest, 1994 , 94 : 877 -884.
[44] Spiecker M, Peng HB , Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBα[J]. J Biol Chem, 1997 , 272 : 30 969 -974
[45] Nie Q ,Fan JL ,Haraoka S ,et al. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats : implications of the ICAM-1 and LFA-1 pathway in atherogenesis[J]. Lab Invest, 1997, 77 : 469 - 482.
[46] Smalley DM, Li JH, Italiano ML, et al. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1[J]. Arterioscler Thromb Vasc Biol, 1996 ,16 : 585 - 590.
[47] Okada M,Matsuto T ,Miida T ,et al. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells [J]. Ann Med Interne Paris, 1997,148: 125-129.
[48] Boisvert WA, Santiago R, Curtiss LK, et al. A leukocyte homoloue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice [J]. Clin Invest, 1998,101: 353-363.
[49] Simonini A, Moscucci M, Muller DW, et al. L-8 is an angiogenic factor in human coronary atherectomy tissue [J]. Circulation, 2000, 101:1519-1526.
[50] Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases:a focus on endothelial responses to inflammation[J]. Clin Sci (Lond), 2005,108:205-213.
[51] Saito M, Ishimitsu T ,Minami J, et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors [J]. Atherosclerosis,2003,167: 73-79.
[52] Tauman R,Ivanenko A, O'Brien LM,et al. Plasma C-reactive protein levels among children with sleep-disordered breathing[J]. Pediatrics, 2004, 113:564-9.
[53] Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome[J]. Sleep, 2007, 30:997-1001.
[54] Boudjeltia KZ, Meerhaeghe AV, Doumit S, et al. Sleep apnea -hypopnea index is an independent predictor of high-sensitivity C-reactive protein elevation [J]. Respiration, 2006, 73: 243-246.
[55]Antoinette Williams & Steven M. Scharf.Obstructive sleep apnea, cardiovascular disease,and inflammation-is NF-kB the key? [J]. Sleep Breath, 2007, 11: 69-76.
[56] Williams A, Steven M. .Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF-kB the key? [J]. Sleep Breath, 2007, 11: 69-76
[57] Ryan S, McNicholas WT, Taylor CT. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia / reoxygenation [J].Biochem Biophys Res Commun, 2007, 355 (3) :728-733.
[58]Ryan S, Taylor CT, McNicholas WT: Predictors of levated nuclear factor kappa B- dependent genes in obstructive sleep apnea syndrome [J]. Am J Respir Crit Care Med, 2006,174: 824-830.
[59] Semenza L. HIF-1 and human disease: one highly involved factor [J]. Genes Dev, 2000,14:1983-1991.
[60] Semenza G. Signal transduction to hypoxia inducible factor-l[J]. Biochem Pharmacol, 2002 ,64 : 993-998.
[61] Huang L E , Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an 02 -dependent degradation domain via the ubiquitin-proteasome pathway [J]. Proc Natl Acad Sci USA, 1998 , 95 (14):7987-7992.
[62] Klimova T, Chandel NS. Mitochondrial complex Ⅲ regulates hypoxic activation of HIF [J]. Cell Death and Differentiation, .2008, (15): 660-666.
[63] Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF-1 hydroxylases[J]. Nat Rev Mol Cell Biol, 2004, 5:343-354.
[64] Silke Ryan, Cormac T. McNicholas, et,al.Selective Activation of Inflammatory Pathways by Intermittent Hypoxia inObstructive Sleep Apnea Syndrome[J]. Circulation, 2005,112:2660-2667.
[65]Toffoli S, Feron O, Raes M, et al. Intermittent hypoxia changes HIF-1α phosphorylation pattern in endothelial cells: Untravelling of a new PKA-dependent regulation of HIF-1α[J]. Biochimical Biophysica Acta, 2007,1773: 1558-1571.
[66] Toffoli S ,Roegiers A, Feron O ,et al. Intermittent hypoxia is an angiogenenic inducer for endothelial cells: role of HIF-1 [J]. Angiogenesis , 2009,12:47-67.
[67] Greenberg HE, Sica AL ,Scharf SM. Expression of C-fos in the rat brainstem after chronic intermit tent hypoxia[J].Brain Res,1999,816 (2):638-645.
[68]康进朝，刘维永，蔡振杰，等．SD 鼠未成熟心肌细胞缺氧／复氧期C-fos，C-myc mRNA的表达[J]．第四军医大学学报，2000，21：586-588．
[69]Yuan G,Adhikary G,Andrew A,et al.Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cell s[J].J Physiol,2004,557 (3):773-783.
[70]Nanduri R,Prabhakar k,kumar.Oxidative stress in the systemic and cellular responses to intermittent hypoxia [J].Biol.Chem,2004,385:217-221.
[71]Williams A,Steven M..Obstructive sleep apnea,cardiovascular disease,and inflammation—is NF-κB the key? [J].Sleep Breath,2007,11:69-76
[72]Ryan S,Taylor CT,McNicholas WT:Predictors of levated nuclear factor kappa B-dependent genes in obstructive sleep apnea syndrome [J].Am J Respir Crit Care Med,2006,174:824-830.
[73]Ciftci TU,Kokturk O,Bukan N,et al.The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome [J].Cytokine,2004,28:87-91.
[74]Minoguchi K,Tazaki T,Yokoe T,et al.Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome [J].Chest,2004,126:1473-1479.
[75]Riha RL,Brander P,Vennelle M,et al:Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome [J].Eur Respir J,2005,26:673-678.
[76]Vgontzas AN,Zoumakis E,Lin HM,et al:Marked decrease in sleepiness in patients with sleep apnea by etanercept,a tumor necrosis factor-alpha antagonist[J].J Clin Endocrinol Metab,2004,89:4409-4413.
[77]Bowen RS,Gu Y,Zhang Y,Lewis DF,et al.Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies [J].J Soc Gynecol Investig,2005,12(6):428-32
[78]Baldwin AS Jr.The NF-kB and IkBα proteins:new discoveries and insights[J].Annu Rev Immunol,1996,14:649-681.
[79]Liao F,Andalibi AI,Qiao JH,et al.Genetic evidence for a common Pathway mediating oxidative stress , inflammatory gene induction , and aortic fatty streak formation in mice[J]. J Clin Invest, 1994 , 94 : 877 -884.
[80] Spiecker M, Peng HB , Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBα[J]. J Biol Chem, 1997 , 272 : 30 969 -974
[81] Nie Q ,Fan JL ,Haraoka S ,et al. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats : implications of the ICAM-1 and LFA-1 pathway in atherogenesis[J]. Lab Invest, 1997, 77 : 469 - 482.
[82] Smalley DM, Li JH , Italiano ML , et al. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1[J]. Arterioscler Thromb Vasc Biol, 1996,16 : 585 - 590.
[83]Okada M,Matsuto T ,Miida T ,et al. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells [J]. Ann Med Interne Paris, 1997,148:125-129.
[84] Matsui H, Ihara Y, Fujio Y et al. Induction of interleukin(IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes[J]. Cardiovasc Res, 1999,42:104-112.
[85] Matsusaka T, Fujikawa K, Nishio Y et al. Transcription factors NFIL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8[J]. Proc Natl Acad Sci USA, 1993, 90:10193-7.
[1]Bickelmann AG,Burwell CS,Robin ED.Extreme obesity associated with alveolar hypoventilation;a Pickwickian syndrome [J].Am J Med.1956,21 (5):811-818.
[2]Gastaut Tasinard,Duren.Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome[J].Rev Neurol (Paris).1965,112(6):568-579
[3]Jung.Physiology and pathophysiology of sleep.Med Welt[J].1965,24:1358-1359
[4]Guilleminault C,Tilkian A,Dement WC.The sleep apnea syndromes[J].Annu Rev Med.1976,27:465-484.
[5]Lopata M,Freilich RA,Onal E,etal.Ventilatory control and the obesity hypoventilation syndrome[J].Am R ev Respir Dis,1979,119(2):165-168.
[6]Young T,Palta M,Dempsey J,et al.The occurrence of sleep-disordered breathing among middle-aged adults[J].N Engl Med,1993,328(17):1230-1235.
[7]上海市医学会呼吸病学分会睡眠呼吸疾病学组上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J]．中华结核和呼吸杂志，2003，05：15-19
[8]张庆；何权瀛；杜秋艳．承德市区居民睡眠呼吸暂停低通气综合征患病率入户调查[J]．中华结核和呼吸杂志，2003，05：20-22．
[9]王蓓，邢景才，韩长旭．太原市睡眠呼吸暂停低通气综合征的流行病学调查[J]．中华结核和呼吸杂志，2004，11：40-42．
[10]Shamsuzzaman AS,Gersh BJ,Somers VK.Obstructive sleep apnea:implications for cardiac and vascular disease[J].JAMA,2003,290:1906-1914
[11]Schulz R,Grebe M,Eisele HJ,etal.Obstructive sleep apnea-related cardiovascular disease Med Klin (Munich) [J].2006,101(4):321-327.
[ 12]Peppard PE,Young T,Palta M,etal.Prospective study of the association between sleep-disordered breathing and hypertension [J].N Engl J Med,2000,342:1378-84.
[13]Peled N,Abinader EG,Pillar G,et al.Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: Effects of continuous positive air pressure treatment[J]. J Am Coll Cardiol , 1999, 34: 1744-1749
[14] Quan SF, Wright R, Baldwin CM, et al. Obstructive sleep apnea-hypoapnea and neurocognitive functioning in the Sleep Heart Health Study[J]. Sleep Med, 2006, 7(6): 498-507.
[15] Reaven GM .Banting lecture 1988. Role of insulin resistance in human disease[J], 1988,37(12): 1595-1607.
[16] Wilcox I, McNamara SG, Collins FL, et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease[J].Thorax, 1998, 53 ( Supp 13): 25 - 28.
[17] Alexandras NV, Bixler EO, Chrousos GP, et al. Sleep apnea is a manifestation of the metabolic syndrome[J]. Sleep Medicine Reviews, 2005, 9: 211 - 224.
[18] Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome[J]. Eur Heart J, 2004,25: 735 - 741.
[19] Reichmuth KJ, Austin D, Skatrud JB, et,al. Association of sleep apnea and type Ⅱ diabetes: a population-based study [J]. Am J Respir Crit Care Med, 2005 , 172(12): 1590-1595.
[20] Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness [J]. J Clin Endocrinol Metab, 1994, 799: 1681 -1685.
[21]Casado-Naranjo I, Ramirez-Moreno JM. Prevalence of breathing disorders during sleep in patients with cerebrovascular disease[J]. Rev Neurol, 2005, 41 Suppl 3:S7-S12.
[22] Haraldsson PO, Akerstedt T. Drowsiness-greater traffic hazard than alcohol. Causes, risks and treatment [J]. Lakartidningen, 2001,98(25):3018-3023.
[23] El-Ad B, Lavie P. Effect of sleep apnea on cognition and mood [J]. Int Rev Psychiatry, 2005, 17(4):277-282.
[24] Schroder CM, O'Hara R. Depression and Obstructive Sleep Apnea (OSA) [J]. Ann Gen Psychiatry, 2005 , 27(4): 13.
[25] Bednarek M, Plywaczewski R, Jonczak L , et al. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study [J]. Respiration, 2005, 72(2):142-149
[26] Sajkov D, Cowie RJ, Thornton AT,etal. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome [J] .Am J Respir Crit Care Med, 1994, 149(2 Pt 1):416-422.
[27] Alkhalil M, Schulman E, Getsy J.Obstructive sleep apnea syndrome and asthma: what are the links? [J]. Clin Sleep Med, 2009, 5(1):71-78.
[28] Alkhalil M, Schulman ES, Getsy J. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment [J]. Ann Allergy Asthma Immunol, 2008,101(4):350-357.
[29] Kim HN, Vorona RD, Winn MP,etal. Symptoms of gastro-oesophageal reflux disease and the severity of obstructive sleep apnoea syndrome are not related in sleep disorders center patients [J].Aliment Pharmacol Ther, 2005, 21(9): 1127-1133.
[30] Savransky V, Bevans S, Nanayakkara A, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver [J]. Am J Physiol Gastrointest Liver Physiol, 2007, 293 (4): 871-877.
[31] Carlson JT, Hedner J, Fagerberg B,etal .Secondary polycythaemia associated with nocturnal apnoea~a relationship not mediated by erythropoietin? [J]. J Intern Med, 1992, 231(4):381-387.
[32] Lavie L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach[J]. Neurol Clin , 2005, 23: 1059-1075.
[33] Vgantzas AN,Papanicolaou DA,Bixler EO.Elevation of plasma cytokines in disorders of excessive daytime sleepiness:role of sleep disturbance and obesity[J].J Clin Endocrinol Metab, 1997, 82:1313-1316.
[34] Shamsuzzaman AS,Winniciki M,Lanfranchi P,et al.Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Cireculation , 2002,105:2462-2464.
[35] Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea[J]. Ann N Y Acad Sci, 2005, 1051:340-350.
[36] Dyugovskaya L, Lavie P,Hirsh M, et al. Actinated CD8~+ lymphocytes in obstructive sleep apnea[J] . Eur Respir J, 2005, 25:820-828.
[37] Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea[J]. Am J Respir Crit Care Med, 2003, 168: 242-249
[38] Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients[J]. Am J Respir Crit Care Med, 2002,165: 934-939.
[39] Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients [J]. Am J Respir Crit Care Med , 2002, 165:934-939.
[40] Zhan G, Serrano F, Fenik P, et al: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea [J]. Am J Respir Crit Care Med [J], 2005,172: 921- 929.
[41]Antoinette Williams & Steven M. Scharf.Obstructive sleep apnea, cardiovascular disease,and inflammation-is NF- kB the key? [J]. Sleep Breath, 2007,11: 69 -76.
[42] Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up[J]. Am J Respir Crit Care Med, 2002, (165): 159-165.
[43] Dureanteau J, Chandel NS, Kulisz A et al. Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes[J]. J Biol Chem, 1998, 273: 11619-11624.
[44] Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from poly morpho nuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy [J]. Am J Respir Crit Care Med,2000, 162: 566-570.
[45] Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and esabilization [J].Stroke,2006,37:1923-1932.
[46]Lavie L.Obstructive sleep apnea syndrome-an oxidative disorder [J].Sleep Med Rev,2003,7:35-51.
[47]McNicholas WT.Obstructive Sleep Apnea and Inflammation [J].Progress in Cardiovascular Diseases,2009,51 (5):392-399
[48]陈宝元，提高对睡眠呼吸暂停模式间歇低氧系统性损伤机制的认识[J]，中华结核和呼吸杂志，2008，31(9)，641-643
[49]IndoH P,Davidson M,Yen H C,et al.Evidence of ROS Generation by Mitochondria in Cells with Impaired Electron Transport Chain and Mitochondrial DNA Damage [J ].Mitochondrion,2007,7(122):106-118.
[50]Schonfeld P,Wojtczak L.Fatty Acids Decrease Mitochondrial Generation of Reactive Oxygen Species at the Reverse Electron Transport but Increase It at the Forward Transport [J].Biochim Biophys Acta,2007,1767 (8):1032-1040.
[51]Sanders SP,Zweier JL,Kuppusamy P et al.Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport[J].J Clin Invest,1993,91:46-52.
[52]Muns G,Rubinstein I,Singer P.Phagocytosis and oxidative burst of granulocytes in t he upper respiratory tract in chronic and acute inflammation [J].J Otolaryngol,1995,24 (2):105-110.
[53]Dyugovskaya L,Lavie P,Lavie L.Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patient s[J].Am J Respir Crit Care Med,2002,165 (7):934-939.
[54]Marshall C,Mamary A J,Verhoeven AJ,et al.Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction [J].Am J Resp Cell Mol Biol,1996,15:633-644.
[55]Ahmadinejad M,Thornton J,Sutton R,et al.Mitochondrial changes following ischaemic2reperfusion injury in the sheep large intestine [J].Indian J of Veterinary Surg,1994,15 (6):126.
[56]褚启龙，杨克敌，王爱国1氧化应激与细胞凋亡关系的研究进展[J]．卫生研究，2003，32(3)：276-278．
[57] McNicholas WT. obstructive sleep apnea and inflammation. Progress in cardiovascular disease [J] ,2009,(51):392-399.
[58] Lavie L. Oxidative Stress-A Unifying Paradigm in Obstructive Sleep Apnea and Comorbidities [J]. Progress in Cardiovascular Diseases, 2009, 51: 303-312
[59] Semenza G. Signal transduction to hypoxia inducible factor-1 [J]. Biochem Pharmacol, 2002 ,64 : 993-998.
[60] Huang L E , Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an 02 -dependent degradation domain via the ubiquitin-proteasome pathway [J]. Proc Natl Acad Sci USA, 1998 , 95 (14): 7987-7992.
[61] Klimova T, Chandel NS. Mitochondrial complex Ⅲ regulates hypoxic activation of HIF [J]. Cell Death and Differentiation, .2008, (15): 660-666.
[62] Semenza L. HIF-1 and human disease: one highly involved factor [J]. Genes Dev,2000,14:1983-1991.
[63] Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF-1 hydroxylases[J]. Nat Rev Mol Cell Biol, 2004, 5:343-354.
[64] Silke Ryan, Cormac T. McNicholas, et,al.Selective Activation of Inflammatory Pathways by Intermittent Hypoxia inObstructive Sleep Apnea Syndrome[J]. Circulation, 2005,112:2660-2667.
[65]Toffoli S, Feron O, Raes M, et al. Intermittent hypoxia changes HIF-1 α phosphorylation pattern in endothelial cells: Untravelling of a new PKA-dependent regulation of HIF-1 α [J]. Biochimical Biophysica Acta ,2007, 1773 : 1558- 1571.
[66]Toffoli S ,Roegiers A, Feron O ,et al. Intermittent hypoxia is an angiogenenic inducer for endothelial cells: role of HIF-1 [J]. Angiogenesis , 2009,12:47-67.
[67] Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Commun, 1989, 161(2): 851-858.
[68] Arindel SR. Roles for VEGF in adult [J]. Microvasc Res, 2007 , 74(2-3):100-113.
[69].Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium[J]. Nature .1995, 6335(376): 66-70.
[70] Couffinhal T, Kearney M, Witzenbichler B, et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries [J]. Am J Pathol, 1997,150(5): 1673-1685.
[71] Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability [J]. FEBS Lett. 1995, 370 (3):203-208.
[72] SenR, BaltimoreD. Multiplenuclear factors interact with the immunoglobulin enhancer sequences [J]. Cell, 1986,46:705 - 716.
[73] Williams A, Steven M..Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF- κ B the key? [J]. Sleep Breath, 2007, 11: 69 - 76
[74] Ryan S, McNicholas WT, Taylor CT. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia / reoxygenation [J]. Biochem Biophys Res Commun, 2007,355 (3) :728- 733.
[75]Ryan S, Taylor CT, McNicholas WT: Predictors of levated nuclear factor kappa B- dependent genes in obstructive sleep apnea syndrome [J]. Am J Respir Crit Care Med, 2006,174: 824-830.
[76] Ciftci TU, Kokturk O, Bukan N, et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome [J]. Cytokine, 2004, 28: 87-91.
[77] Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome [J]. Chest, 2004, 126:1473-1479.
[78] Riha RL, Brander P, Vennelle M, et al: Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome [J]. Eur Respir J, 2005, 26: 673-678.
[79] Vgontzas AN, Zoumakis E, Lin HM, et al: Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist[J]. J Clin Endocrinol Metab , 2004, 89:4409-4413.
[80] Bowen RS, Gu Y, Zhang Y, Lewis DF,et al. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies [J]. J Soc Gynecol Investig, 2005,12(6):428-32
[81] Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies[J]. J Soc Gynecol Invest, 2005, 12:428-432.
[82] Matsui H, Ihara Y, Fujio Y et al. Induction of interleukin(IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes[J]. Cardiovasc Res , 1999,42:104-112.
[83] Matsusaka T, Fujikawa K, Nishio Y et al. Transcription factors NFIL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8[J]. Proc Natl Acad Sci USA, 1993, 90:10193-7.
[84] Semenza GL. Oxygen-regulated transcription factors and their role in pulmonary disease[J]. Respir Res, 2000,1:159-62.
[85] Yan SF, Tritto I, Pinsky D et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor IL-6 [J]. J Biol Chem,1995,270: 11463-71.
[86] Luc G, Bard JM, Juhan-Vague I, et al. C-Reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study[J]. Arterioscler Thromb Vasc Biol, 2003, 23:1255-1261.
[87] Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996, 94: 874-877.
[88] Ueda K, Takahashi M, Ozawa K, et al. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction [J]. Am Heart J, 1999,138(5 Pt 1):908-915.
[89] Baldwin AS Jr. The NF2kB and IkBα proteins : new discoveries and insights[J]. Annu Rev Immunol, 1996 , 14 : 649 - 681.
[90]Liao F , Andalibi AI ,Qiao JH , et al. Genetic evidence for a common Pathway mediating oxidative stress , inflammatory gene induction, and aortic fatty streak formation in mice[J]. J Clin Invest, 1994 , 94 : 877 -884.
[91] Spiecker M, Peng HB , Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBa[J]. J Biol Chem, 1997 ,272 : 30 969 -974
[92] Nie Q ,Fan JL ,Haraoka S ,et al. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats : implications of the ICAM-1 and LFA-1 pathway in atherogenesis[J]. Lab Invest, 1997, 77 : 469 -482.
[93] Smalley DM, Li JH , Italiano ML , et al. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1 [J]. Arterioscler Thromb Vasc Biol, 1996 ,16 : 585-590.
[94]Okada M,Matsuto T ,Miida T ,et al. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells [J]. Ann Med Interne Paris, 1997,148:125-129.
[95] Boisvert WA, Santiago R, Curtiss LK, et al. A leukocyte homoloue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice [J]. Clin Invest, 1998,101: 353-363.
[96] Simonini A, Moscucci M, Muller DW, et al. L-8 is an angiogenic factor in human coronary atherectomy tissue [J]. Circulation, 2000,101:1519-1526.
[97] Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases:a focus on endothelial responses to inflammation[J]. Clin Sci (Lond), 2005,108:205-213.
[98] Saito M, Ishimitsu T ,Minami J, et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors [J]. Atherosclerosis , 2003,167: 73-79.
[99] Tauman R, Ivanenko A, O'Brien LM,et al. Plasma C-reactive protein levels among children with sleep-disordered breathing[J]. Pediatrics, 2004, 113:564-9.
[100] Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome [J]. Sleep, 2007, 30:997-1001.
[101] Boudjeltia KZ, Meerhaeghe AV, Doumit S, et al. Sleep apnea-hypopnea index is an independent predictor of high-sensitivity C-reactive protein elevation [J].Respiration,2006,73:243-246.
[102]Greenberg HE,Sica AL,Scharf SM.Expression of C-fos in the rat brainstem after chronic intermit tent hypoxia[J].Brain Res,1999,816 (2):638-645.
[103]康进朝，刘维永，蔡振杰，等．SD 鼠未成熟心肌细胞缺氧／复氧期c-fos，c-myc mRNA的表达[J]．第四军医大学学报，2000，21：586-588．
[104]Yuan G,Adhikary G,Andrew A,et al.Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC 12 cell s[J].J Physiol,2004,557 (3):773-783.
[2]Young T,Palta M,Dempsey J,et al.The occurrence of sleep-disordered breathing among middle-aged adults[J].N Engl Med,1993,328(17):1230-1235.
[3]Shamsuzzaman AS,Gersh B J,Somers VK.Obstructive sleep apnea:implications for cardiac and vascular disease [J].JAMA,2003,290:1906-1914
[4]Schulz R,Grebe M,Eisele HJ,etal.Obstructive sleep apnea-related cardiovascular disease Med Klin (Munich) [J].2006,101(4):321-327.
[5]Peppard PE,Young T,Palta M,etal.Prospective study of the association between sleep-disordered breathing and hypertension [J].N Engl J Med,2000,342:1378-84.
[6]Quan SF,Wright R,Baldwin CM,et al.Obstructive sleep apnea-hypoapnea and neurocognitive functioning in the Sleep Heart Health Study[J].Sleep Med,2006,7(6):498-507.
[7]Fletcher EC,Lesske J,Qian W,et al.episodic hypoxia causes diurnal elevation of blood pressure in rats [J].Hypertension,1992,19:555-561.
[8]Fletcher EC,Bao G,Miller CC 3~(rd).Effect of recurrent episodic hypocapnic,eucapnic,and hypercapnic hypoxia on systemic blood pressure [J].J Appl Physiol,1995,78:1516-1521.
[9]Fletcher EC,Bao G.Effect of episodic eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension-prone rats [J].J Appl Physiol,1996,81(5):2088-2094.
[10]Lavie L.Sleep-disordered breathing and cerebrovascular disease:a mechanistic approach [J].Neurol Clin,2005,23:1059-1075.
[11]Vgantzas AN,Papanicolaou DA,Bixler EO.Elevation of plasma cytokines in disorders of excessive daytime sleepiness:role of sleep disturbance and obesity [J]. J Clin Endocrinol Metab, 1997, 82:1313-1316.
[12] Shamsuzzaman AS,Winniciki M,Lanfranchi P,et al.Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Cireculation , 2002, 105:2462-2464.
[13] Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea[J]. Ann N Y Acad Sci, 2005,1051:340-350.
[14] Dyugovskaya L, Lavie P,Hirsh M, et al. Actinated CD8~+ lymphocytes in obstructive sleep apnea[J]. Eur Respir J, 2005,25:820-828.
[15] Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea[J]. Am J Respir Crit Care Med, 2003, 168: 242-249
[16] Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients[J]. Am J Respir Crit Care Med, 2002,165: 934-939.
[17] Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients [J]. Am J Respir Crit Care Med , 2002, 165:934-939.
[18] Zhan G, Serrano F, Fenik P, et al: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea [J]. Am J Respir Crit Care Med [J], 2005,172: 921- 929.
[19] Antoinette W, Steven M.. Obstructive sleep apnea cardiovascular disease,and inflammation-is NF-kB the key? [J]. Sleep Breath, 2007, 11: 69-76.
[20] Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up [J]. Am J Respir Crit Care Med, 2002, (165): 159-165.
[21] Dureanteau J, Chandel NS, Kulisz A et al. Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes[J]. J Biol Chem, 1998, 273: 11619-11624.
[22] Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from poly morpho nuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy [J]. Am J Respir Crit Care Med, 2000,162: 566-570.
[23] Lavie L. Obstructive sleep apnea syndrome -an oxidative disorder [J] . Sleep Med Rev, 2003, 7:35-51.
[24] McNicholas WT. Obstructive Sleep Apnea and Inflammation [J]. Progress in Cardiovascular Diseases, 2009, 51(5): 392-399.
[25] Bassenge E, Schneider HT, Daiber A. Oxidative stress and cardiovascular diseases[J ]. Dtsch Med Wochenschr, 2005 ,130(50): 2904-2909.
[26] Heistad DD. Oxidative stress and vascular disease [J ]. Arterioscler Thromb Vasc Biol, 2005,12:104.
[27] Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients[J]. Am J Respir Crit Care Med, 2002,165: 934-939.
[28] Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients [J]. Am J Respir Crit Care Med , 2002, 165:934-939.
[29] Zhan G, Serrano F, Fenik P, et al: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea [J]. Am J Respir Crit Care Med [J], 2005,172: 921- 929.
[30] Dean RT,Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep aonea [J] .Sleep, 1993, 16: S15-21.
[31] Halliwell B. The role of oxygen radicals in human disease,with particular reference to the vascular system [J]. Haemostasis, 1993, 23: 118-126.
[32] Dureanteau J, Chandel NS, Kulisz A et al. Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes [J] . J Biol Chem, 1998,273: 11619-11624.
[33] Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from poly morpho nuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy [J]. Am J Respir Crit Care Med, 2000, 162: 566-570.
[34] Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and esabilization [J]. Stroke, 2006, 37:1923-1932.
[35] Sanders SP, Zweier JL, Kuppusamy P et al. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron Transport [J]. J Clin Invest, 1993, 91: 46-52.
[36] Marshall C, Mamary AJ, Verhoeven AJ,et al. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction [J]. Am J Resp Cell Mol Biol,1996,15:633-644.
[37] Ahmadinejad M, Thornton J , Sutton R, et al. Mitochondrial changes following ischaemic-reperfusion injury in the sheep large intestine [J] . Indian J of Veterinary Surg, 1994 ,15 (6) :126.
[38] Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension [J]. N Engl J Med, 2000, 342: 1378-84.
[39] Luc G, Bard JM, Juhan-Vague I, et al. C-Reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study[J].Arterioscler Thromb Vasc Biol, 2003, 23:1255-1261.
[40] Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996, 94: 874-877.
[41] Ueda K, Takahashi M, Ozawa K, et al. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction [J]. Am Heart J, 1999,138(5 Pt 1): 908-915.
[42] Baldwin AS Jr. The NF-kB and IkBα proteins : new discoveries and insights[J]. Annu Rev Immunol, 1996 , 14 : 649 - 681.
[43] Liao F , Andalibi AI ,Qiao JH , et al. Genetic evidence for a common Pathway mediating oxidative stress , inflammatory gene induction , and aortic fatty streak formation in mice[J]. J Clin Invest, 1994 , 94 : 877 -884.
[44] Spiecker M, Peng HB , Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBα[J]. J Biol Chem, 1997 , 272 : 30 969 -974
[45] Nie Q ,Fan JL ,Haraoka S ,et al. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats : implications of the ICAM-1 and LFA-1 pathway in atherogenesis[J]. Lab Invest, 1997, 77 : 469 - 482.
[46] Smalley DM, Li JH, Italiano ML, et al. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1[J]. Arterioscler Thromb Vasc Biol, 1996 ,16 : 585 - 590.
[47] Okada M,Matsuto T ,Miida T ,et al. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells [J]. Ann Med Interne Paris, 1997,148: 125-129.
[48] Boisvert WA, Santiago R, Curtiss LK, et al. A leukocyte homoloue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice [J]. Clin Invest, 1998,101: 353-363.
[49] Simonini A, Moscucci M, Muller DW, et al. L-8 is an angiogenic factor in human coronary atherectomy tissue [J]. Circulation, 2000, 101:1519-1526.
[50] Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases:a focus on endothelial responses to inflammation[J]. Clin Sci (Lond), 2005,108:205-213.
[51] Saito M, Ishimitsu T ,Minami J, et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors [J]. Atherosclerosis,2003,167: 73-79.
[52] Tauman R,Ivanenko A, O'Brien LM,et al. Plasma C-reactive protein levels among children with sleep-disordered breathing[J]. Pediatrics, 2004, 113:564-9.
[53] Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome[J]. Sleep, 2007, 30:997-1001.
[54] Boudjeltia KZ, Meerhaeghe AV, Doumit S, et al. Sleep apnea -hypopnea index is an independent predictor of high-sensitivity C-reactive protein elevation [J]. Respiration, 2006, 73: 243-246.
[55]Antoinette Williams & Steven M. Scharf.Obstructive sleep apnea, cardiovascular disease,and inflammation-is NF-kB the key? [J]. Sleep Breath, 2007, 11: 69-76.
[56] Williams A, Steven M. .Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF-kB the key? [J]. Sleep Breath, 2007, 11: 69-76
[57] Ryan S, McNicholas WT, Taylor CT. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia / reoxygenation [J].Biochem Biophys Res Commun, 2007, 355 (3) :728-733.
[58]Ryan S, Taylor CT, McNicholas WT: Predictors of levated nuclear factor kappa B- dependent genes in obstructive sleep apnea syndrome [J]. Am J Respir Crit Care Med, 2006,174: 824-830.
[59] Semenza L. HIF-1 and human disease: one highly involved factor [J]. Genes Dev, 2000,14:1983-1991.
[60] Semenza G. Signal transduction to hypoxia inducible factor-l[J]. Biochem Pharmacol, 2002 ,64 : 993-998.
[61] Huang L E , Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an 02 -dependent degradation domain via the ubiquitin-proteasome pathway [J]. Proc Natl Acad Sci USA, 1998 , 95 (14):7987-7992.
[62] Klimova T, Chandel NS. Mitochondrial complex Ⅲ regulates hypoxic activation of HIF [J]. Cell Death and Differentiation, .2008, (15): 660-666.
[63] Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF-1 hydroxylases[J]. Nat Rev Mol Cell Biol, 2004, 5:343-354.
[64] Silke Ryan, Cormac T. McNicholas, et,al.Selective Activation of Inflammatory Pathways by Intermittent Hypoxia inObstructive Sleep Apnea Syndrome[J]. Circulation, 2005,112:2660-2667.
[65]Toffoli S, Feron O, Raes M, et al. Intermittent hypoxia changes HIF-1α phosphorylation pattern in endothelial cells: Untravelling of a new PKA-dependent regulation of HIF-1α[J]. Biochimical Biophysica Acta, 2007,1773: 1558-1571.
[66] Toffoli S ,Roegiers A, Feron O ,et al. Intermittent hypoxia is an angiogenenic inducer for endothelial cells: role of HIF-1 [J]. Angiogenesis , 2009,12:47-67.
[67] Greenberg HE, Sica AL ,Scharf SM. Expression of C-fos in the rat brainstem after chronic intermit tent hypoxia[J].Brain Res,1999,816 (2):638-645.
[68]康进朝，刘维永，蔡振杰，等．SD 鼠未成熟心肌细胞缺氧／复氧期C-fos，C-myc mRNA的表达[J]．第四军医大学学报，2000，21：586-588．
[69]Yuan G,Adhikary G,Andrew A,et al.Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cell s[J].J Physiol,2004,557 (3):773-783.
[70]Nanduri R,Prabhakar k,kumar.Oxidative stress in the systemic and cellular responses to intermittent hypoxia [J].Biol.Chem,2004,385:217-221.
[71]Williams A,Steven M..Obstructive sleep apnea,cardiovascular disease,and inflammation—is NF-κB the key? [J].Sleep Breath,2007,11:69-76
[72]Ryan S,Taylor CT,McNicholas WT:Predictors of levated nuclear factor kappa B-dependent genes in obstructive sleep apnea syndrome [J].Am J Respir Crit Care Med,2006,174:824-830.
[73]Ciftci TU,Kokturk O,Bukan N,et al.The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome [J].Cytokine,2004,28:87-91.
[74]Minoguchi K,Tazaki T,Yokoe T,et al.Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome [J].Chest,2004,126:1473-1479.
[75]Riha RL,Brander P,Vennelle M,et al:Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome [J].Eur Respir J,2005,26:673-678.
[76]Vgontzas AN,Zoumakis E,Lin HM,et al:Marked decrease in sleepiness in patients with sleep apnea by etanercept,a tumor necrosis factor-alpha antagonist[J].J Clin Endocrinol Metab,2004,89:4409-4413.
[77]Bowen RS,Gu Y,Zhang Y,Lewis DF,et al.Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies [J].J Soc Gynecol Investig,2005,12(6):428-32
[78]Baldwin AS Jr.The NF-kB and IkBα proteins:new discoveries and insights[J].Annu Rev Immunol,1996,14:649-681.
[79]Liao F,Andalibi AI,Qiao JH,et al.Genetic evidence for a common Pathway mediating oxidative stress , inflammatory gene induction , and aortic fatty streak formation in mice[J]. J Clin Invest, 1994 , 94 : 877 -884.
[80] Spiecker M, Peng HB , Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBα[J]. J Biol Chem, 1997 , 272 : 30 969 -974
[81] Nie Q ,Fan JL ,Haraoka S ,et al. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats : implications of the ICAM-1 and LFA-1 pathway in atherogenesis[J]. Lab Invest, 1997, 77 : 469 - 482.
[82] Smalley DM, Li JH , Italiano ML , et al. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1[J]. Arterioscler Thromb Vasc Biol, 1996,16 : 585 - 590.
[83]Okada M,Matsuto T ,Miida T ,et al. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells [J]. Ann Med Interne Paris, 1997,148:125-129.
[84] Matsui H, Ihara Y, Fujio Y et al. Induction of interleukin(IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes[J]. Cardiovasc Res, 1999,42:104-112.
[85] Matsusaka T, Fujikawa K, Nishio Y et al. Transcription factors NFIL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8[J]. Proc Natl Acad Sci USA, 1993, 90:10193-7.
[1]Bickelmann AG,Burwell CS,Robin ED.Extreme obesity associated with alveolar hypoventilation;a Pickwickian syndrome [J].Am J Med.1956,21 (5):811-818.
[2]Gastaut Tasinard,Duren.Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome[J].Rev Neurol (Paris).1965,112(6):568-579
[3]Jung.Physiology and pathophysiology of sleep.Med Welt[J].1965,24:1358-1359
[4]Guilleminault C,Tilkian A,Dement WC.The sleep apnea syndromes[J].Annu Rev Med.1976,27:465-484.
[5]Lopata M,Freilich RA,Onal E,etal.Ventilatory control and the obesity hypoventilation syndrome[J].Am R ev Respir Dis,1979,119(2):165-168.
[6]Young T,Palta M,Dempsey J,et al.The occurrence of sleep-disordered breathing among middle-aged adults[J].N Engl Med,1993,328(17):1230-1235.
[7]上海市医学会呼吸病学分会睡眠呼吸疾病学组上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J]．中华结核和呼吸杂志，2003，05：15-19
[8]张庆；何权瀛；杜秋艳．承德市区居民睡眠呼吸暂停低通气综合征患病率入户调查[J]．中华结核和呼吸杂志，2003，05：20-22．
[9]王蓓，邢景才，韩长旭．太原市睡眠呼吸暂停低通气综合征的流行病学调查[J]．中华结核和呼吸杂志，2004，11：40-42．
[10]Shamsuzzaman AS,Gersh BJ,Somers VK.Obstructive sleep apnea:implications for cardiac and vascular disease[J].JAMA,2003,290:1906-1914
[11]Schulz R,Grebe M,Eisele HJ,etal.Obstructive sleep apnea-related cardiovascular disease Med Klin (Munich) [J].2006,101(4):321-327.
[ 12]Peppard PE,Young T,Palta M,etal.Prospective study of the association between sleep-disordered breathing and hypertension [J].N Engl J Med,2000,342:1378-84.
[13]Peled N,Abinader EG,Pillar G,et al.Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: Effects of continuous positive air pressure treatment[J]. J Am Coll Cardiol , 1999, 34: 1744-1749
[14] Quan SF, Wright R, Baldwin CM, et al. Obstructive sleep apnea-hypoapnea and neurocognitive functioning in the Sleep Heart Health Study[J]. Sleep Med, 2006, 7(6): 498-507.
[15] Reaven GM .Banting lecture 1988. Role of insulin resistance in human disease[J], 1988,37(12): 1595-1607.
[16] Wilcox I, McNamara SG, Collins FL, et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease[J].Thorax, 1998, 53 ( Supp 13): 25 - 28.
[17] Alexandras NV, Bixler EO, Chrousos GP, et al. Sleep apnea is a manifestation of the metabolic syndrome[J]. Sleep Medicine Reviews, 2005, 9: 211 - 224.
[18] Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome[J]. Eur Heart J, 2004,25: 735 - 741.
[19] Reichmuth KJ, Austin D, Skatrud JB, et,al. Association of sleep apnea and type Ⅱ diabetes: a population-based study [J]. Am J Respir Crit Care Med, 2005 , 172(12): 1590-1595.
[20] Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness [J]. J Clin Endocrinol Metab, 1994, 799: 1681 -1685.
[21]Casado-Naranjo I, Ramirez-Moreno JM. Prevalence of breathing disorders during sleep in patients with cerebrovascular disease[J]. Rev Neurol, 2005, 41 Suppl 3:S7-S12.
[22] Haraldsson PO, Akerstedt T. Drowsiness-greater traffic hazard than alcohol. Causes, risks and treatment [J]. Lakartidningen, 2001,98(25):3018-3023.
[23] El-Ad B, Lavie P. Effect of sleep apnea on cognition and mood [J]. Int Rev Psychiatry, 2005, 17(4):277-282.
[24] Schroder CM, O'Hara R. Depression and Obstructive Sleep Apnea (OSA) [J]. Ann Gen Psychiatry, 2005 , 27(4): 13.
[25] Bednarek M, Plywaczewski R, Jonczak L , et al. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study [J]. Respiration, 2005, 72(2):142-149
[26] Sajkov D, Cowie RJ, Thornton AT,etal. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome [J] .Am J Respir Crit Care Med, 1994, 149(2 Pt 1):416-422.
[27] Alkhalil M, Schulman E, Getsy J.Obstructive sleep apnea syndrome and asthma: what are the links? [J]. Clin Sleep Med, 2009, 5(1):71-78.
[28] Alkhalil M, Schulman ES, Getsy J. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment [J]. Ann Allergy Asthma Immunol, 2008,101(4):350-357.
[29] Kim HN, Vorona RD, Winn MP,etal. Symptoms of gastro-oesophageal reflux disease and the severity of obstructive sleep apnoea syndrome are not related in sleep disorders center patients [J].Aliment Pharmacol Ther, 2005, 21(9): 1127-1133.
[30] Savransky V, Bevans S, Nanayakkara A, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver [J]. Am J Physiol Gastrointest Liver Physiol, 2007, 293 (4): 871-877.
[31] Carlson JT, Hedner J, Fagerberg B,etal .Secondary polycythaemia associated with nocturnal apnoea~a relationship not mediated by erythropoietin? [J]. J Intern Med, 1992, 231(4):381-387.
[32] Lavie L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach[J]. Neurol Clin , 2005, 23: 1059-1075.
[33] Vgantzas AN,Papanicolaou DA,Bixler EO.Elevation of plasma cytokines in disorders of excessive daytime sleepiness:role of sleep disturbance and obesity[J].J Clin Endocrinol Metab, 1997, 82:1313-1316.
[34] Shamsuzzaman AS,Winniciki M,Lanfranchi P,et al.Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Cireculation , 2002,105:2462-2464.
[35] Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea[J]. Ann N Y Acad Sci, 2005, 1051:340-350.
[36] Dyugovskaya L, Lavie P,Hirsh M, et al. Actinated CD8~+ lymphocytes in obstructive sleep apnea[J] . Eur Respir J, 2005, 25:820-828.
[37] Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea[J]. Am J Respir Crit Care Med, 2003, 168: 242-249
[38] Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients[J]. Am J Respir Crit Care Med, 2002,165: 934-939.
[39] Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients [J]. Am J Respir Crit Care Med , 2002, 165:934-939.
[40] Zhan G, Serrano F, Fenik P, et al: NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea [J]. Am J Respir Crit Care Med [J], 2005,172: 921- 929.
[41]Antoinette Williams & Steven M. Scharf.Obstructive sleep apnea, cardiovascular disease,and inflammation-is NF- kB the key? [J]. Sleep Breath, 2007,11: 69 -76.
[42] Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up[J]. Am J Respir Crit Care Med, 2002, (165): 159-165.
[43] Dureanteau J, Chandel NS, Kulisz A et al. Intracellular signaling by Reactive Oxygen Species during hypoxia in Cardiomyocytes[J]. J Biol Chem, 1998, 273: 11619-11624.
[44] Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from poly morpho nuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy [J]. Am J Respir Crit Care Med,2000, 162: 566-570.
[45] Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and esabilization [J].Stroke,2006,37:1923-1932.
[46]Lavie L.Obstructive sleep apnea syndrome-an oxidative disorder [J].Sleep Med Rev,2003,7:35-51.
[47]McNicholas WT.Obstructive Sleep Apnea and Inflammation [J].Progress in Cardiovascular Diseases,2009,51 (5):392-399
[48]陈宝元，提高对睡眠呼吸暂停模式间歇低氧系统性损伤机制的认识[J]，中华结核和呼吸杂志，2008，31(9)，641-643
[49]IndoH P,Davidson M,Yen H C,et al.Evidence of ROS Generation by Mitochondria in Cells with Impaired Electron Transport Chain and Mitochondrial DNA Damage [J ].Mitochondrion,2007,7(122):106-118.
[50]Schonfeld P,Wojtczak L.Fatty Acids Decrease Mitochondrial Generation of Reactive Oxygen Species at the Reverse Electron Transport but Increase It at the Forward Transport [J].Biochim Biophys Acta,2007,1767 (8):1032-1040.
[51]Sanders SP,Zweier JL,Kuppusamy P et al.Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport[J].J Clin Invest,1993,91:46-52.
[52]Muns G,Rubinstein I,Singer P.Phagocytosis and oxidative burst of granulocytes in t he upper respiratory tract in chronic and acute inflammation [J].J Otolaryngol,1995,24 (2):105-110.
[53]Dyugovskaya L,Lavie P,Lavie L.Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patient s[J].Am J Respir Crit Care Med,2002,165 (7):934-939.
[54]Marshall C,Mamary A J,Verhoeven AJ,et al.Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction [J].Am J Resp Cell Mol Biol,1996,15:633-644.
[55]Ahmadinejad M,Thornton J,Sutton R,et al.Mitochondrial changes following ischaemic2reperfusion injury in the sheep large intestine [J].Indian J of Veterinary Surg,1994,15 (6):126.
[56]褚启龙，杨克敌，王爱国1氧化应激与细胞凋亡关系的研究进展[J]．卫生研究，2003，32(3)：276-278．
[57] McNicholas WT. obstructive sleep apnea and inflammation. Progress in cardiovascular disease [J] ,2009,(51):392-399.
[58] Lavie L. Oxidative Stress-A Unifying Paradigm in Obstructive Sleep Apnea and Comorbidities [J]. Progress in Cardiovascular Diseases, 2009, 51: 303-312
[59] Semenza G. Signal transduction to hypoxia inducible factor-1 [J]. Biochem Pharmacol, 2002 ,64 : 993-998.
[60] Huang L E , Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an 02 -dependent degradation domain via the ubiquitin-proteasome pathway [J]. Proc Natl Acad Sci USA, 1998 , 95 (14): 7987-7992.
[61] Klimova T, Chandel NS. Mitochondrial complex Ⅲ regulates hypoxic activation of HIF [J]. Cell Death and Differentiation, .2008, (15): 660-666.
[62] Semenza L. HIF-1 and human disease: one highly involved factor [J]. Genes Dev,2000,14:1983-1991.
[63] Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF-1 hydroxylases[J]. Nat Rev Mol Cell Biol, 2004, 5:343-354.
[64] Silke Ryan, Cormac T. McNicholas, et,al.Selective Activation of Inflammatory Pathways by Intermittent Hypoxia inObstructive Sleep Apnea Syndrome[J]. Circulation, 2005,112:2660-2667.
[65]Toffoli S, Feron O, Raes M, et al. Intermittent hypoxia changes HIF-1 α phosphorylation pattern in endothelial cells: Untravelling of a new PKA-dependent regulation of HIF-1 α [J]. Biochimical Biophysica Acta ,2007, 1773 : 1558- 1571.
[66]Toffoli S ,Roegiers A, Feron O ,et al. Intermittent hypoxia is an angiogenenic inducer for endothelial cells: role of HIF-1 [J]. Angiogenesis , 2009,12:47-67.
[67] Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Commun, 1989, 161(2): 851-858.
[68] Arindel SR. Roles for VEGF in adult [J]. Microvasc Res, 2007 , 74(2-3):100-113.
[69].Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium[J]. Nature .1995, 6335(376): 66-70.
[70] Couffinhal T, Kearney M, Witzenbichler B, et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries [J]. Am J Pathol, 1997,150(5): 1673-1685.
[71] Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability [J]. FEBS Lett. 1995, 370 (3):203-208.
[72] SenR, BaltimoreD. Multiplenuclear factors interact with the immunoglobulin enhancer sequences [J]. Cell, 1986,46:705 - 716.
[73] Williams A, Steven M..Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF- κ B the key? [J]. Sleep Breath, 2007, 11: 69 - 76
[74] Ryan S, McNicholas WT, Taylor CT. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia / reoxygenation [J]. Biochem Biophys Res Commun, 2007,355 (3) :728- 733.
[75]Ryan S, Taylor CT, McNicholas WT: Predictors of levated nuclear factor kappa B- dependent genes in obstructive sleep apnea syndrome [J]. Am J Respir Crit Care Med, 2006,174: 824-830.
[76] Ciftci TU, Kokturk O, Bukan N, et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome [J]. Cytokine, 2004, 28: 87-91.
[77] Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome [J]. Chest, 2004, 126:1473-1479.
[78] Riha RL, Brander P, Vennelle M, et al: Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome [J]. Eur Respir J, 2005, 26: 673-678.
[79] Vgontzas AN, Zoumakis E, Lin HM, et al: Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist[J]. J Clin Endocrinol Metab , 2004, 89:4409-4413.
[80] Bowen RS, Gu Y, Zhang Y, Lewis DF,et al. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies [J]. J Soc Gynecol Investig, 2005,12(6):428-32
[81] Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies[J]. J Soc Gynecol Invest, 2005, 12:428-432.
[82] Matsui H, Ihara Y, Fujio Y et al. Induction of interleukin(IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes[J]. Cardiovasc Res , 1999,42:104-112.
[83] Matsusaka T, Fujikawa K, Nishio Y et al. Transcription factors NFIL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8[J]. Proc Natl Acad Sci USA, 1993, 90:10193-7.
[84] Semenza GL. Oxygen-regulated transcription factors and their role in pulmonary disease[J]. Respir Res, 2000,1:159-62.
[85] Yan SF, Tritto I, Pinsky D et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor IL-6 [J]. J Biol Chem,1995,270: 11463-71.
[86] Luc G, Bard JM, Juhan-Vague I, et al. C-Reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study[J]. Arterioscler Thromb Vasc Biol, 2003, 23:1255-1261.
[87] Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996, 94: 874-877.
[88] Ueda K, Takahashi M, Ozawa K, et al. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction [J]. Am Heart J, 1999,138(5 Pt 1):908-915.
[89] Baldwin AS Jr. The NF2kB and IkBα proteins : new discoveries and insights[J]. Annu Rev Immunol, 1996 , 14 : 649 - 681.
[90]Liao F , Andalibi AI ,Qiao JH , et al. Genetic evidence for a common Pathway mediating oxidative stress , inflammatory gene induction, and aortic fatty streak formation in mice[J]. J Clin Invest, 1994 , 94 : 877 -884.
[91] Spiecker M, Peng HB , Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBa[J]. J Biol Chem, 1997 ,272 : 30 969 -974
[92] Nie Q ,Fan JL ,Haraoka S ,et al. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats : implications of the ICAM-1 and LFA-1 pathway in atherogenesis[J]. Lab Invest, 1997, 77 : 469 -482.
[93] Smalley DM, Li JH , Italiano ML , et al. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1 [J]. Arterioscler Thromb Vasc Biol, 1996 ,16 : 585-590.
[94]Okada M,Matsuto T ,Miida T ,et al. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells [J]. Ann Med Interne Paris, 1997,148:125-129.
[95] Boisvert WA, Santiago R, Curtiss LK, et al. A leukocyte homoloue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice [J]. Clin Invest, 1998,101: 353-363.
[96] Simonini A, Moscucci M, Muller DW, et al. L-8 is an angiogenic factor in human coronary atherectomy tissue [J]. Circulation, 2000,101:1519-1526.
[97] Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases:a focus on endothelial responses to inflammation[J]. Clin Sci (Lond), 2005,108:205-213.
[98] Saito M, Ishimitsu T ,Minami J, et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors [J]. Atherosclerosis , 2003,167: 73-79.
[99] Tauman R, Ivanenko A, O'Brien LM,et al. Plasma C-reactive protein levels among children with sleep-disordered breathing[J]. Pediatrics, 2004, 113:564-9.
[100] Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome [J]. Sleep, 2007, 30:997-1001.
[101] Boudjeltia KZ, Meerhaeghe AV, Doumit S, et al. Sleep apnea-hypopnea index is an independent predictor of high-sensitivity C-reactive protein elevation [J].Respiration,2006,73:243-246.
[102]Greenberg HE,Sica AL,Scharf SM.Expression of C-fos in the rat brainstem after chronic intermit tent hypoxia[J].Brain Res,1999,816 (2):638-645.
[103]康进朝，刘维永，蔡振杰，等．SD 鼠未成熟心肌细胞缺氧／复氧期c-fos，c-myc mRNA的表达[J]．第四军医大学学报，2000，21：586-588．
[104]Yuan G,Adhikary G,Andrew A,et al.Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC 12 cell s[J].J Physiol,2004,557 (3):773-783.